Alkeus Launches Phase 3 Stargardt Trial - Quiz - MDSpire

Alkeus Launches Phase 3 Stargardt Trial

At OIS Retina, Carlos Quezada Ruiz, MD, highlighted the launch of the global phase 3 NORTHSTAR trial evaluating investigational oral gildeuretinol for Stargardt disease.

  • By

  • Carlos Quezada Ruiz, MD

  • July 15, 2026

  • 2 min

Share

Original Source(s)

Alkeus Launches Phase 3 Stargardt Trial

  • by Carlos Quezada Ruiz, MD

  • July 15, 2026

Related Content

Effects of Nd: YAG laser capsulotomy on central macular thickness: a systematic review and meta-analysis

ORG Detects Retinal Dysfunction Before Structural Changes

At ASRS 2026, Kareem Moussa, MD, presented early data suggesting optoretinography may identify photoreceptor dysfunction in diabetic eyes before conventional imaging reveals abnormalities.

"Landmark" Dataset Maps Anterior Segment Disease

Moorfields and UCL launch dataset aiming to accelerate research into anterior segment conditions

  • July 16, 2026

  • 2 min